Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2017

Mar 15, 2017

30681_dirs_2017-03-15_749727c2-9f47-44ec-9594-783c47c37cb9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2017-03-10

Reporting Person: BRADBURY DANIEL (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-10 Common Stock G 10000 $0.00 Disposed 155575 Indirect